- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01559441
Beetroot Juice and Postprandial Vascular Activity
The Effects of Beetroot Juice on Postprandial Vascular Activity After a High-fat Meal in Overweight and Slightly Obese Men
Increased postprandial lipemia may increase the risk for cardiovascular diseases. An important mechanistic link between lipemia following a high-fat meal and adverse cardiovascular events is lipid-mediated endothelial activation. Therefore, it is important to identify nutrients that can neutralize this acute vascular disturbance.
The investigators hypothesize that beetroot juice, a food rich in inorganic nitrate, could improve vascular activity during the postprandial phase.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Maastricht, Netherlands
- Maastricht University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged between 18 and 70 years
- Quetelet-index between 28-35 kg/m2
- Mean serum triacylglycerol ≤1.7 mmol/L
- No indication for treatment with cholesterol-lowering drugs according to the Dutch Cholesterol Consensus
- No current smoker
- No diabetic patients or individuals receiving antidiabetic medication
- No familial hypercholesterolemia
- No abuse of drugs
- Less than 21 alcoholic consumptions per week
- Stable body weight (weight gain or loss <3 kg in the past three months)
- No use of medication known to affect serum lipid metabolism
- No severe medical conditions that might interfere with the study, such as high blood pressure, epilepsy, asthma, allergies, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis
- No active cardiovascular disease like congestive heart failure or recent (<6 months) event (acute myocardial infarction, cerebro vascular accident)
- Willingness to stop the consumption of foods rich in nitrates 3 weeks before the start of the study. Vegetables such as beets, celery, radishes, turnips and spinach are rich in nitrates
- Willingness to give up being a blood donor (or having donated blood) from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study
- No difficult venipuncture as evidenced during the screening visits
Exclusion Criteria:
- Women
- Quetelet-index between <28 or >35 kg/m2
- Mean serum triacylglycerol ≥1.7 mmol/L
- Indication for treatment with cholesterol-lowering drugs according to the Dutch Cholesterol Consensus
- Current smoker
- Diabetic patients or individuals receiving antidiabetic medication
- Familial hypercholesterolemia
- Abuse of drugs
- More than 21 alcoholic consumptions per week
- Unstable body weight (weight gain or loss >3 kg in the past three months)
- Use of use of medication known to affect serum lipid metabolism
- No severe medical conditions that might interfere with the study, such as high blood pressure, epilepsy, asthma, allergies, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis
- Active cardiovascular disease like congestive heart failure or recent (<6 months) event (acute myocardial infarction, cerebro vascular accident)
- Use of an investigational product within the previous 1 month
- Not willing to stop the consumption of foods rich in nitrates 3 weeks before the start of the study
- Not willing to give up being a blood donor (or having donated blood) from 8 weeks before the start of the study, during the study or for 4 weeks after completion of the study
- Not or difficult to venipuncture as evidenced during the screening visits
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Beetroot juice
|
140mL (9.6 mmol nitrate) beetroot juice (Beet It, James White drinks Ltd)
|
Placebo Comparator: Carbohydrate control drink
|
140 mL (low-nitrate) carbohydrate control drink
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vascular activity
Time Frame: Change from baseline at 2 hours after meal consumption
|
Flow-mediated dilation (FMD) of the brachial artery
|
Change from baseline at 2 hours after meal consumption
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Arterial stiffness
Time Frame: Change from baseline at 3 hours after meal consumption
|
Pulse wave analysis (PWA) and velocity (PWV)
|
Change from baseline at 3 hours after meal consumption
|
Microcirculatory effects
Time Frame: Change from baseline at 3 hours after meal consumption
|
Retinal imaging
|
Change from baseline at 3 hours after meal consumption
|
Metabolic risk markers related to the metabolic syndrome
Time Frame: During 4 hours after meal consumption
|
Changes in biomarkers for low-grade systemic inflammation and endothelial activation.
|
During 4 hours after meal consumption
|
Postprandial lipid metabolism
Time Frame: During 4 hours after meal consumption
|
During 4 hours after meal consumption
|
|
Postprandial glucose metabolism
Time Frame: During 4 hours after meal consumption
|
During 4 hours after meal consumption
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- METC 11-3-085
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyslipidemia
-
Kowa Research Institute, Inc.CompletedMixed Dyslipidemia | Primary DyslipidemiaUnited States
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemia (Fredrickson Type Ⅱa) | Dyslipidemia (Fredrickson Type Ⅱb)Korea, Republic of
-
Hanlim Pharm. Co., Ltd.RecruitingMixed DyslipidemiaKorea, Republic of
-
IlDong Pharmaceutical Co LtdNot yet recruiting
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
Provident Clinical ResearchReliant PharmaceuticalsCompleted
-
Arrowhead PharmaceuticalsActive, not recruitingMixed DyslipidemiaUnited States, Australia, Canada, New Zealand
-
Yooyoung Pharmaceutical Co., Ltd.CompletedCombined DyslipidemiaKorea, Republic of
-
Société des Produits Nestlé (SPN)CompletedPrimary DyslipidemiaChina
-
Provident Clinical ResearchReliant PharmaceuticalsUnknown
Clinical Trials on Beetroot Juice with oral fat load
-
National Institute of Cardiology, Laranjeiras,...Completed
-
Sulaimany Polytechnic universityCompletedNAFLD, Non-alcoholic Fatty Liver DiseaseIraq
-
Emory UniversityAmerican Heart AssociationCompletedHypertension | Endothelial DysfunctionUnited States
-
Danone ResearchCompletedMildly Hypercholesterolemic SubjectsItaly
-
Danone SpainCompletedHypercholesterolemiaSpain
-
Emory UniversityAmerican Diabetes AssociationCompletedHypertension | Obesity | DiabetesUnited States
-
Instituto de Investigación Sanitaria Gregorio MarañónCompletedAlcohol ConsumptionSpain
-
Liverpool Heart and Chest Hospital NHS Foundation...Completed